DXCM

Dexcom

$67.40

-1.03 (-1.51%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$85.35
(+26.63%)
Strong Buy: 5
Buy: 20
Hold: 4
Sell: 0
Strong Sell: 0
Description:
DexCom, Inc. is a leading innovator in diabetes management, best known for its advanced continuous glucose monitoring (CGM) systems that enable patients to maintain optimal glucose levels. Headquartered in San Diego, California, with a manufacturing facility in Mesa, Arizona, DexCom is committed to enhancing the quality of life for individuals with diabetes through cutting-edge technology and superior product offerings. The company is expanding its global footprint to address the increasing demand for reliable diabetes management solutions, solidifying its role as a pivotal player in the healthcare sector.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
6340 SEQUENCE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121
Fiscal year end:
December
Market capitalization:
$26.4 Billion
EBITDA:
$1.02 Billion
PERatio:
37.44
EPS:
1.8
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.483

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+224%
How much will you get:
$3,242
Prices dates:
31-12-2015: $20.48 and 31-12-2025: $66.37